190 related articles for article (PubMed ID: 37257548)
21. A metagenomic study of the gut microbiome in Behcet's disease.
Ye Z; Zhang N; Wu C; Zhang X; Wang Q; Huang X; Du L; Cao Q; Tang J; Zhou C; Hou S; He Y; Xu Q; Xiong X; Kijlstra A; Qin N; Yang P
Microbiome; 2018 Aug; 6(1):135. PubMed ID: 30077182
[TBL] [Abstract][Full Text] [Related]
22. Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet's disease: A systematic review and meta-analysis.
Iizuka Y; Takase-Minegishi K; Hirahara L; Kirino Y; Soejima Y; Namkoong HO; Horita N; Yoshimi R; Takeuchi M; Takeno M; Mizuki N; Nakajima H
Mod Rheumatol; 2022 Oct; 32(6):1153-1162. PubMed ID: 34752620
[TBL] [Abstract][Full Text] [Related]
23. A double-blind trial of colchicine in Behçet's syndrome.
Yurdakul S; Mat C; Tüzün Y; Ozyazgan Y; Hamuryudan V; Uysal O; Senocak M; Yazici H
Arthritis Rheum; 2001 Nov; 44(11):2686-92. PubMed ID: 11710724
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of apremilast for 3 months in Behçet's disease: A prospective observational study.
Hirahara L; Kirino Y; Soejima Y; Takeno M; Takase-Minegishi K; Yoshimi R; Takeuchi M; Mizuki N; Nakajima H
Mod Rheumatol; 2021 Jul; 31(4):856-861. PubMed ID: 32996801
[TBL] [Abstract][Full Text] [Related]
25. The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study.
Mat MC; Goksugur N; Engin B; Yurdakul S; Yazici H
Int J Dermatol; 2006 May; 45(5):554-6. PubMed ID: 16700790
[TBL] [Abstract][Full Text] [Related]
26. [Behçet's disease - Infliximab in the treatment of mucocutaneous manifestations].
Lestre S; Trindade F; Martins A; Baptista J; Feio AB; Lopes MJ
Acta Reumatol Port; 2009; 34(4):633-40. PubMed ID: 20852576
[TBL] [Abstract][Full Text] [Related]
27. How to recognise a Behçet's ulcer from other types of oral ulceration? Defining Behçet's ulceration by an International Delphi Consultation.
Poveda-Gallego A; Chapple I; Iacucci M; Hamburger J; Murray PI; Rauz S; Wallace GR;
Clin Exp Rheumatol; 2023 Oct; 41(10):2048-2055. PubMed ID: 37902271
[TBL] [Abstract][Full Text] [Related]
28. Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.
Ishido T; Horita N; Takeuchi M; Kawagoe T; Shibuya E; Yamane T; Hayashi T; Meguro A; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Ishigatsubo Y; Takeno M; Kurosawa M; Kaneko T; Mizuki N
Rheumatology (Oxford); 2017 Nov; 56(11):1918-1927. PubMed ID: 28968732
[TBL] [Abstract][Full Text] [Related]
29. Comparative Analysis of Primers Used for 16S rRNA Gene Sequencing in Oral Microbiome Studies.
Na HS; Song Y; Yu Y; Chung J
Methods Protoc; 2023 Aug; 6(4):. PubMed ID: 37623922
[TBL] [Abstract][Full Text] [Related]
30. Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice.
Atienza-Mateo B; Martín-Varillas JL; Graña J; Espinosa G; Moriano C; Pérez-Sandoval T; García-Armario MD; Castellví I; Román-Ivorra JA; Olivé A; Ybáñez A; Martinez-Ferrer A; Narváez J; Romero-Yuste S; Ojeda S; Ros I; Loricera J; Calvo-Río V; Castañeda S; Gonzalez-Gay MA; Blanco R;
Clin Exp Rheumatol; 2020; 38 Suppl 127(5):69-75. PubMed ID: 33331268
[TBL] [Abstract][Full Text] [Related]
31. Erosive arthritis in a patient with Behçet's disease.
Düzgün N; Ateş A
Rheumatol Int; 2003 Sep; 23(5):265-7. PubMed ID: 12879263
[TBL] [Abstract][Full Text] [Related]
32. Current therapy for Behçet's disease.
Goker B; Goker H
Am J Ther; 2002; 9(5):465-70. PubMed ID: 12237740
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of Behcet's disease in Mongolia: a multicenter study.
Balt J; Jamyanjav B; Jav S; Dandii Z; Ganbold C; Horie Y; Lennikov A; Uehara O; Ohno S; Kitaichi N
Clin Rheumatol; 2020 Sep; 39(9):2697-2706. PubMed ID: 32157471
[TBL] [Abstract][Full Text] [Related]
34. An accurate and efficient experimental approach for characterization of the complex oral microbiota.
Zheng W; Tsompana M; Ruscitto A; Sharma A; Genco R; Sun Y; Buck MJ
Microbiome; 2015 Oct; 3():48. PubMed ID: 26437933
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Outcome of Ustekinumab Therapy for Behçet's Disease.
Mirouse A; Barete S; Desbois AC; Comarmond C; Sène D; Domont F; Bodaghi B; Ferfar Y; Cacoub P; Saadoun D;
Arthritis Rheumatol; 2019 Oct; 71(10):1727-1732. PubMed ID: 31008548
[TBL] [Abstract][Full Text] [Related]
36. Exploring protocol bias in airway microbiome studies: one versus two PCR steps and 16S rRNA gene region V3 V4 versus V4.
Drengenes C; Eagan TML; Haaland I; Wiker HG; Nielsen R
BMC Genomics; 2021 Jan; 22(1):3. PubMed ID: 33397283
[TBL] [Abstract][Full Text] [Related]
37. Radiological neuro-Behçet's associated with bipolar disorder: first presentation of a multisystem disease.
Hibberd O; Bhomra P; Ahmad A
J R Coll Physicians Edinb; 2018 Dec; 48(4):323-327. PubMed ID: 30488887
[TBL] [Abstract][Full Text] [Related]
38. [Ulcerations of the extremities: An unusual manifestation of Behçet's disease].
Mejri M; Said F; Khanfir M; Chelly I; Haouet S; Habib H
Rev Med Interne; 2019 Feb; 40(2):117-119. PubMed ID: 30193781
[TBL] [Abstract][Full Text] [Related]
39. Lack of association between serum IL-9 levels and Behçet's disease.
Nouri-Vaskeh M; Malek Mahdavi A; Khabbazi A; Jadideslam G
Immunol Lett; 2019 Jul; 211():23-27. PubMed ID: 31095970
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience.
De Luca G; Cariddi A; Campochiaro C; Vanni D; Boffini N; Tomelleri A; Cavalli G; Dagna L
Rheumatology (Oxford); 2020 Jan; 59(1):171-175. PubMed ID: 31280296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
